333 related articles for article (PubMed ID: 11111090)
21. The Caveolin genes: from cell biology to medicine.
Williams TM; Lisanti MP
Ann Med; 2004; 36(8):584-95. PubMed ID: 15768830
[TBL] [Abstract][Full Text] [Related]
22. Distinction between signaling mechanisms in lipid rafts vs. caveolae.
Sowa G; Pypaert M; Sessa WC
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14072-7. PubMed ID: 11707586
[TBL] [Abstract][Full Text] [Related]
23. Caveolins and cellular cholesterol balance.
Ikonen E; Parton RG
Traffic; 2000 Mar; 1(3):212-7. PubMed ID: 11208104
[TBL] [Abstract][Full Text] [Related]
24. Sterol efflux to apolipoprotein A-I originates from caveolin-rich microdomains and potentiates PDGF-dependent protein kinase activity.
Fielding PE; Russel JS; Spencer TA; Hakamata H; Nagao K; Fielding CJ
Biochemistry; 2002 Apr; 41(15):4929-37. PubMed ID: 11939788
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae.
Hong S; Huo H; Xu J; Liao K
Cell Death Differ; 2004 Jul; 11(7):714-23. PubMed ID: 15002041
[TBL] [Abstract][Full Text] [Related]
26. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
Smythe GM; Eby JC; Disatnik MH; Rando TA
J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
[TBL] [Abstract][Full Text] [Related]
27. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.
Drab M; Verkade P; Elger M; Kasper M; Lohn M; Lauterbach B; Menne J; Lindschau C; Mende F; Luft FC; Schedl A; Haller H; Kurzchalia TV
Science; 2001 Sep; 293(5539):2449-52. PubMed ID: 11498544
[TBL] [Abstract][Full Text] [Related]
28. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis.
Pike LJ; Han X; Chung KN; Gross RW
Biochemistry; 2002 Feb; 41(6):2075-88. PubMed ID: 11827555
[TBL] [Abstract][Full Text] [Related]
29. Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling.
Costa MJ; Song Y; Macours P; Massart C; Many MC; Costagliola S; Dumont JE; Van Sande J; Vanvooren V
Endocrinology; 2004 Mar; 145(3):1464-72. PubMed ID: 14670987
[TBL] [Abstract][Full Text] [Related]
30. Caveolins: structure and function in signal transduction.
Krajewska WM; Masłowska I
Cell Mol Biol Lett; 2004; 9(2):195-220. PubMed ID: 15213803
[TBL] [Abstract][Full Text] [Related]
31. Sterol carrier protein-2 directly interacts with caveolin-1 in vitro and in vivo.
Zhou M; Parr RD; Petrescu AD; Payne HR; Atshaves BP; Kier AB; Ball JM; Schroeder F
Biochemistry; 2004 Jun; 43(23):7288-306. PubMed ID: 15182174
[TBL] [Abstract][Full Text] [Related]
32. Caveolin, cholesterol, and lipid bodies.
Martin S; Parton RG
Semin Cell Dev Biol; 2005 Apr; 16(2):163-74. PubMed ID: 15797827
[TBL] [Abstract][Full Text] [Related]
33. Caveolae and lipid rafts: G protein-coupled receptor signaling microdomains in cardiac myocytes.
Insel PA; Head BP; Ostrom RS; Patel HH; Swaney JS; Tang CM; Roth DM
Ann N Y Acad Sci; 2005 Jun; 1047():166-72. PubMed ID: 16093494
[TBL] [Abstract][Full Text] [Related]
34. Caveolae and intracellular trafficking of cholesterol.
Fielding CJ; Fielding PE
Adv Drug Deliv Rev; 2001 Jul; 49(3):251-64. PubMed ID: 11551398
[TBL] [Abstract][Full Text] [Related]
35. From embryonic development to human diseases: The functional role of caveolae/caveolin.
Sohn J; Brick RM; Tuan RS
Birth Defects Res C Embryo Today; 2016 Mar; 108(1):45-64. PubMed ID: 26991990
[TBL] [Abstract][Full Text] [Related]
36. Regulated interaction of endothelin B receptor with caveolin-1.
Yamaguchi T; Murata Y; Fujiyoshi Y; Doi T
Eur J Biochem; 2003 Apr; 270(8):1816-27. PubMed ID: 12694195
[TBL] [Abstract][Full Text] [Related]
37. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance.
Pol A; Luetterforst R; Lindsay M; Heino S; Ikonen E; Parton RG
J Cell Biol; 2001 Mar; 152(5):1057-70. PubMed ID: 11238460
[TBL] [Abstract][Full Text] [Related]
38. Caveolins in cholesterol trafficking and signal transduction: implications for human disease.
Schlegel A; Pestell RG; Lisanti MP
Front Biosci; 2000 Dec; 5():D929-37. PubMed ID: 11102315
[TBL] [Abstract][Full Text] [Related]
39. Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae.
Vainio S; Heino S; Mansson JE; Fredman P; Kuismanen E; Vaarala O; Ikonen E
EMBO Rep; 2002 Jan; 3(1):95-100. PubMed ID: 11751579
[TBL] [Abstract][Full Text] [Related]
40. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
Hnasko R; Lisanti MP
Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
